SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors

Summary

The main purpose of this study is to assess the safety and tolerability of SHR-1701 at different dose levels. Study consists of dose-escalation part and an expansion part in subjects with metastatic or locally advanced solid tumors.

Timeline

Start

2019-01-24

Primary completion

2023-03

Completion

2023-12

Drugs

Indications